Skip to content
by Legal Desire
28 December 2023

Latham & Watkins Advises Homology Medicines in Merger Agreement With Q32 Bio

Advising firms

Deal team

22 lawyers named
LawyerFirmSeniorityPracticeOffice
Leah Sauter Lead Latham & Watkins LLP Partner corporate Not stated
Peter Handrinos Lead Latham & Watkins LLP Partner corporate Not stated
Elizabeth Slawsby Latham & Watkins LLP Associate corporate Not stated
Junhan Zhang Latham & Watkins LLP Associate corporate Not stated
Katharine Moir Latham & Watkins LLP Partner tax Not stated
Rasha Suleiman Latham & Watkins LLP Associate tax Not stated
Derek Gumm Latham & Watkins LLP Associate tax Not stated
Matt Conway Latham & Watkins LLP Partner benefits Not stated
Ashlie Lawton Latham & Watkins LLP Associate benefits Not stated
Dane Rebkowec Latham & Watkins LLP Associate benefits Not stated
Bryce Williamson Latham & Watkins LLP Associate benefits Not stated
Colleen Smith Latham & Watkins LLP Partner litigation Not stated
Steven Chinowsky Latham & Watkins LLP Partner intellectual property Not stated
Robert Yeh Latham & Watkins LLP Associate intellectual property Not stated
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Elisabeth Martin Latham & Watkins LLP Partner capital markets Not stated
Nicholas Reist Latham & Watkins LLP Associate capital markets Not stated
Ashley Dunn Latham & Watkins LLP Associate capital markets Not stated
Jenna Cooper Latham & Watkins LLP Partner public company representation Not stated
Nicole McNeil Latham & Watkins LLP Counsel public company representation Not stated
Hanna Downing Latham & Watkins LLP Associate public company representation Not stated
Patrick English Latham & Watkins LLP Counsel antitrust Not stated

19 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Homology Medicines, Inc.Sell-side
Counterparties
Q32 Bio Inc. (Buy-side)